SPECIALIZED IN FIRST-IN-HUMAN FROM DAY ONE

Your Reliable Partner In Early Phase
MANAGEMENT BOARD

Get to know our leadership-team and their special field of experience that provides value to your research.

How we work

SHORT APPROVAL TIMES
30 days from submission to approval due to our monocentric approach and parallel submission to ca and ec/irb.
RELIABLE RECRUITING
We provide fast recruitment of suitable patients with well established medical records.
FAST TRIAL CONDUCT
Average duration for a single dose trial in renal impaired patients is 4-6 months.
HIGH STANDARDISATION
Our setup allows the mono-centric conduct of complex pk trials with challenging requirements for the study population, avoiding inter-centre variability and guaranteeing highest quality according to phase-I standards.
PATIENT SAFETY
The infrastructure and expertise enables us to work according to the best ethical and medical practice regarding the vulnerable study population.
WE SCALE WITH YOUR BUSINESS
Our specialization in early-phase trials benefits all types of businesses in need of rapid and valid testing. This is true for start-up companies in need of assistance and expertise in this phase and large corporations alike.